C12Y 204/01041
Polypeptide n-acetylgalactosaminyltransferase
Official title: Polypeptide N-acetylgalactosaminyltransferase (2.4.1.41)
C12Y204/01041 (Polypeptide n-acetylgalactosaminyltransferase) appears on 6 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 11
- Assignees
- 11
- Inventors
- 50
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 2 |
| 2015 | 2 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Sugar composition containing cyclic tetrasaccharide, use thereof, and production method therefor2 Jun 2026US 12,644,142 B2Nagase Viita Co., Ltd.
- CRISPR/Cas9 vector combination and application thereof in gene knockout23 Nov 2021US 11,180,763 B2Nanjing Genefriend-Biotech Inc.
- Compositions and methods for treatment of melanoma23 Aug 2016US 9,421,218 B2New York University
- Bladder cancer tumor marker, antibody and use thereof7 Jul 2015US 9,073,995 B2Institute of Biophysics, Chinese Academy of Sciences
- Recombinant prokaryotes and use thereof for production of O-glycosylated proteins9 Jun 2015US 9,051,593 B2Trustees of Dartmouth College
- Compositions and methods relating to age-related, neurological, and vascular disease conditions20 Aug 2026US 2026/0241037 A1The Board of Trustees of the Leland Stanford Junior University
- Cd44 glycoepitopes and chimeric vaccine glycoconjugates for cancer therapy and synthesis methods thereof30 Oct 2025US 2025/0333475 A1I3S - Instituto De InvestigaçãO E InovaçãO Em SAúDe, AssociaçãO
- Sugar composition containing cyclic tetrasaccharide, use thereof, and production method therefor3 Aug 2023US 2023/0242957 A1Nagase Viita Co., Ltd.
- Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins1 Dec 2022US 2022/0380785 A1The University of British Columbia
- Crispr/cas9 vector combination and application thereof in gene knockout7 Jan 2021US 2021/0002652 A1Nanjing Genefriend-Biotech Inc.
Most cited
By later US patents